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Mitochondrial proteasesIn mammalian cells the nuclear-encoded subunits of complex I are imported into mitochondria, where they are
assembled with mt-DNA encoded subunits in the complex, or exchanged with pre-existing copies in the complex.
The present work shows that in ﬁbroblast cultures inhibition by KH7 of cAMP production in themitochondrial ma-
trix by soluble adenylyl cyclase (sAC) results in decreased amounts of free non-incorporated nuclear-encoded
NDUFS4, NDUFV2 and NDUFA9 subunits of the catalytic moiety and inhibition of the activity of complex I. Addition
of permeant 8-Br-cAMP prevents this effect of KH7. KH7 inhibits accumulation in isolated rat-liver mitochondria
and incorporation in complex I of “in vitro” produced, radiolabeled NDUFS4 and NDUFV2 subunits. 8-Br-cAMP
prevents also this effect of KH7. Use of protease inhibitors shows that intramitochondrial cAMP exerts this positive
effect on complex I by preventing digestion of nuclear-encoded subunits by mitochondrial protease(s), whose
activity is promoted by KH7 and H89, an inhibitor of PKA.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
In mammals, complex I has 44 constituent subunits [1,2]. Fourteen
are conserved from prokaryotes to humans; the others are termed
supernumerary subunits. Seven of the conserved subunits are encoded
by the mitochondrial DNA (mtDNA), all the others by nuclear genes
[3,4]. Complex I biogenesis is thus a concerted process in which
intramitochondrial expression of themtDNA-encoded subunits is coordi-
nated with extramitochondrial expression of the nuclear DNA-encoded
subunits, their import and maturation in mitochondria, where, in a step-
wise process, a copy of each subunit is assembled in the mature complex
[5]. In addition to “de novo” biogenesis of the entire complex, nuclearicmonophosphate; CAI, carbonic
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+39 080 5448538.encoded subunits, belonging to the matrix exposed catalytic moiety of
the complex, undergo a relatively rapid turnover, with exchange of pre-
existing with newly synthesized copies [6,7]. This exchange contributes
to replace “aged”, oxidatively damaged, subunits in the complex with
new ones, thus preserving its functional activity [8].
The cAMP signal system,which functions at the crossroads of several
cellular signal transduction networks, exerts a major role in the biogene-
sis and post-translational processing and activity of complex I (reviewed
in [9]). cAMP produced in the cytosol primes, through phosphorylation
by PKAof the cAMP response element protein (CREB) [10,11], the nuclear
PGC-1α transcriptional cascade of respiratory chain complexes [12]. In
addition, in mitochondria CREB phosphorylation by PKA activates the
expression of mitochondrial genes of respiratory chain complexes, in-
cluding seven subunits of complex I [13–15].
Previouswork from our laboratory has shown that addition to cell
cultures of the membrane permeant derivate of cAMP, 8-Br-cAMP
(8-bromoadenosine 3′,5′-cyclic monophosphate), and, equally effective,
activation of transmembrane adenylyl cyclase (tmAC) by cholera toxin
[16] or the β-adrenoceptor agonist, isoproterenol [17], rescue the depres-
sion of complex I activity and the increase in cellular ROS level observed
in murine and human ﬁbroblast cultures in the G0 phase [18] and in ox-
idatively damaged cell cultures [8]. Other investigations showed that
phosphorylation by extramitochondrial PKA of serine in the C-terminus
RVS conserved site of the nuclear-encoded NDUFS4 subunit of complex
I [19,20] promotesmitochondrial import andmaturation of the precursor
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of the mature form of the protein [21].
In the mitochondrial matrix a soluble, bicarbonate-sensitive,
adenylyl cyclase (sAC) [22] and all the members of the cAMP/PKA sys-
tem are present [23–27]. It has been found that sAC-dependent cAMP
production in mitochondria promotes cytochrome c oxidase activity,
through phosphorylation of complex IV subunit IV-I [28], ATP pro-
duction [29], and the mitochondrial pathway of apoptosis [30]. It
has to be stressed that tmAC and sAC catalyze separate production
of cAMP in the cytosol and in the mitochondrial-matrix respectively,
being the mitochondrial membrane impermeable to the cyclic
nucleotide.
In the presentworkwe show that, in human ﬁbroblast cultures KH7,
which inhibits intramitohondrial cAMP production by sAC [31] and ac-
etazolamide a carbonic anhydrase inhibitor (CAI) [32,33], depressed
complex I activity, to the same extent as the inhibition of cytochrome
c oxidase [34]. The KH7-induced depression of both enzymes was
rescued by the addition of the membrane permeant 8-Br-cAMP, but
not by the increase of cytosolic cAMP induced by isoproterenol. The de-
pression of complex I activity caused by KH7 in ﬁbroblast cultures was
associated with decrease of the amount of nuclear-encoded NDUFS4,
NDUFV2 and NDUFA9 subunits of complex I, which was also rescued
by 8-Br-cAMP, but not by isoproterenol. It is also shown that KH7 de-
pressed the accumulation in isolated rat-liver mitochondria (RLM) of
“in vitro” expressed [35S] labeled NDUFS4 and NDUFV2 subunits and
their incorporation in complex I, this inhibition too being rescued by
8-Br-cAMP. Using protease inhibitors, evidence is obtained showing
that intramitochondrial cAMP prevents the KH7-induced degradation
of thenon-incorporatedpool of these complex I subunits bymitochondri-
al protease(s) and the inhibition of its activity. These ﬁndings showing an
additional, critical role of cAMP in the regulation of complex I, provide
new insight in mitochondrial pathophysiology.
2. Materials and methods
2.1. Cell cultures
Neonatal normal human dermal ﬁbroblasts (NHDF-neo, Cambrex
#CC-2509, East Rutherford, NJ, USA) were grown in the exponential
phase in high glucose Dulbecco's modiﬁed Eagle's medium (DMEM)
(EuroClone, Paignton, UK) supplemented with 10% fetal bovine serum
(FBS), plus 2 mM glutamine, 100 IU/ml penicillin and 100 IU/ml strep-
tomycin (Euroclone, Paignton, UK) at 37 °C, 5% CO2. Further conditions
are speciﬁed in the legends to ﬁgures.
2.2. Chemicals
[35S] Met/Cys (1000 Ci/mmol) (Perkin Elmer, Milano, Italy), 8-Br-
cAMP (Biolog Life Science Institute, Germany), Acetazolamide
(Sigma-Aldrich, St. Louis, MO), catalytic subunit cAMP-dependent
protein kinase (cPKA) (Promega, Mannheim, Germany), epoxomicin
(Sigma-Aldrich, St. Louis, MO), KH7 (E-2-(1H-Benzo[d]imidazol-2-
ylthio)-N′-(5-bromo-2-hydroxybenzylidene)propanehydrazide)
(Sigma-Aldrich, St. Louis, MO), MG132 (Sigma-Aldrich, St. Louis, MO),
Protein kinase A inhibitor (PKI) (Sigma-Aldrich, St. Louis, MO).
2.3. Spectroﬂuorimetric analysis
Intracellular H2O2 level was determined by the cell permeant probe
2′-7′dichlorodihydroﬂuorescin diacetate (H2DCFDA) (Sigma-Aldrich,
St. Louis, MO). Cells were incubated with 10 μM H2DCFDA in DMEM.
After 20 min incubation in the dark at 37 °C, the cells were collected by
trypsinization, washed and resuspended in the assay buffer (100mMpo-
tassiumphosphate, pH 7.4, 2mMMgCl2). An aliquotwas used for protein
concentration determination. The probe ﬂuorescence intensity (507 nmexcitation and 530 nm emission wavelengths) was measured by a Jasco
FP6200 spectroﬂuorimeter (see also ref. [17]).
2.4. Mitoplast and inner mitochondrial membrane preparation
NHDF-neo cells were harvested fromPetri disheswith 0.05% trypsin,
0.02% EDTA, pelleted by centrifugation at 500 ×g and then resuspended
in phosphate-buffered saline, pH 7.4 (PBS). The cell suspension was ex-
posed for 10 min on ice to 2 mg of digitonin/mg cellular protein and
then centrifuged at 14,000 ×g. The pellet (mitoplast fraction) was
resuspended in PBS. The inner mitochondrial membrane fraction was
obtained by mitoplast exposure to ultrasounds and sedimentation by
centrifugation at 100,000 ×g for 1 h. After centrifugation the pellet
was resupended in PBS.
2.5. Rat liver mitochondria isolation
Mitochondria were isolated from rat liver as described in [21].
2.6. Enzymatic spectrophotometric assays
Isolated mitoplasts were exposed to ultrasound energy for 15 s at
0 °C to allow complete accessibility of substrates to enzymes.
The NADH-UQ oxidoreductase activity (complex I) was performed
in 40mMpotassium phosphate buffer, pH 7.4, 5mMMgCl2, in the pres-
ence of 3 mM KCN, 1 μg/ml antimycin, 200 μM decylubiquinone, using
30 μg of mitoplast proteins, by following the oxidation of 100 μM
NADH at 340–425 nm (Δε = 6.81 mM−1 cm−1). The activity was
corrected for the residual activity measured in the presence of 1 μg/ml
rotenone.
Cytochrome c oxidase (complex IV) activity was measured by fol-
lowing the oxidation of 10 μM ferrocytochrome c at 550–540 nm
(Δε= 19.1 mM−1cm−1). Enzymatic activity was measured in 10 mM
phosphate buffer, pH 7.4, using 20 μg of mitoplast proteins. This rate
was inhibited over 95% by KCN (2 mM).
Succinate-cytochrome c oxidoreductase (complex II + III) activity
was measured at 550–540 nm (Δε= 19.1 mM−1 cm−1) as the initial
rate of antimycin-sensitive cytochrome c reduction.
2.7. cAMP assay
Cellswere harvested frompetri disheswith 0.05% trypsin, 0.02% EDTA
and pelleted by centrifugation at 500 ×g. The cell pellet resuspended in
PBS was utilized for homogenate preparation, by potterization, and for
mitoplast preparation as described above. The samples of the homoge-
nate and mitoplast were checked for lactate dehydrogenase activity.
cAMP level was measured in the homogenate and mitoplast samples
using a direct immunoassay kit (Assay Designs, Ann Arbor, Michigan,
USA) as described by the manufacturer. Total protein concentration was
determined by Bio Rad protein assay. The cAMP level measured in
mitoplast fraction was corrected for contamination by the homogenate,
evaluated by lactic dehydrogenase activity.
2.8. Electrophoretic procedures and western blotting
Proteins from ﬁbroblast cell lysate, mitoplast fraction or their inner
membrane fraction were separated by 12% SDS-polyacrylamide gel elec-
trophoresis (PAGE) and transferred to a nitrocellulose membrane. The
membrane was blocked with 5% fatty acid free dry milk in 500 mM
NaCl, 20 mM Tris, 0.05% Tween 20 pH 7.4 (TTBS) for 3 h at 4 °C and
probed with antibodies against NDUFS4 (Thermo scientiﬁc, Pierce Anti-
bodies, Lausanne Switzerland), NDUFA9, NDUFB6, COX IV, β-ATPase,
Core II (Invitrogen, Paisley, UK), NDUFV2 (Cell Signalling, Danvers, MA,
USA), NDUFB11 (Prim SRL, Milan, Italy) and actin (Sigma-Aldrich,
St. Louis, MO). After beingwashed in TTBS, themembrane was incubat-
ed for 60 min with antirabbit or antimouse IgG peroxidase-conjugated
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further TTBS washes, with the enhanced chemiluminescence (ECL)
(Euroclone, Paignton, UK).
Separation of oxidative phosphorylation complexes was performed
by two-dimensional blue-native electrophoresis (BNE)/SDS-PAGE.
Mitoplast fraction or RLM (50 μg) were suspended in 750 mM
aminocaproic acid, 50 mM Bis–Tris, 0.5 mM EDTA plus 1% or 0.4% (w/v)
lauryl maltoside, respectively. Protein were loaded on 5%–12% gradient
native-gel followed by a second dimension in 12% SDS-PAGE. After the
electrophoretic separation the proteinswere transferred to nitrocellulose
and immunoblotted with the NDUFA9, NDUFB6, COX IV, β-ATPase and
Core II antibodies described above. Densitometric analysis was per-
formed by VersaDoc imaging system (BioRad, Milan, Italy).2.9. cDNA constructs, in vitro translation and import assay
Full-length humanNDUFS4 andNDUFB11 cDNAswere generated by
reverse transcriptase-PCR, using RNA extracted from primary ﬁbroblasts
from skin biopsies of control subjects. The cDNAs were cloned in
pCDNA3.1(+) vector with the T7 promoter as described in [21]. Plasmid
constructions were conﬁrmed by DNA sequencing. The full-length
human NDUFV2 cDNA was purchased from OriGene Technologies
(Rockville, MD, USA).
In vitro transcription/translation of cDNAs was performed in rabbit
reticulocyte lysate (RRL) system (Promega Biotech, Madison,WI) as re-
ported in [21]. Essentially, 1 μg of construct was added to 50 μl Promega
standardmixture, containing T7 RNA polymerase and a standard amino
acid mixture with [35S]Methionine/Cysteine (20 μCi). Incubation was
done at 30 °C for 90 min.
5 μl of radioactive RRL translation mixture was added to the import
mixture containing: rat liver mitochondria (500 μg proteins), 210 mM
mannitol, 7 mM Hepes, pH 7.4, 0.35 mMMgCl2, 2.5 mg/ml BSA, 3 mM
ATP, 3mMGTP, 15mMmalate, 30mMpyruvate and 1 mg/ml chloram-
phenicol; ﬁnal volume 200 μl. Incubation was done at 30 °C. After incu-
bation, aliquots of the mixture were transferred to ice-cooled tubes and
supplemented with protease inhibitors (1 μl per 250 μg mitochondrial
proteins). Mitochondria were spun down from the import mixture at
4000×g and 50 μgmitochondrial proteins of each samplewere separated
by SDS-PAGE and/or BNE (see also [8]). After electrophoresis the gels
were dried. Radioactive protein bands were detected by Personal FX at
“phosphorus imager” (BioRad, Milan, Italy) and quantiﬁed by VersaDoc
(BioRad, Milan, Italy).2.10. Proteolytic activity assay
90 μg rat liver mitochondria were incubated in the absence or in the
presence of KH7, 8-Br-cAMP,MG132 or epoxomicin at 30 °C in 210mM
mannitol, 7mMHepes, pH 7.4, 0.35mMMgCl2. After 15min incubation,
0.2% w/v Triton X-100, 0.25 μM protein kinase A inhibitor (PKI), 5 μM
okadaic acid, and 2 mM ATP (Sigma-Aldrich, St. Louis, MO) were
added, before adding 12 μg casein. The incubation was, then, prolonged
and aliquots ofmitochondrial proteinswere taken at the times speciﬁed
in Fig. 7 and resuspended in SDS-lysis buffer. Proteinswere separated by
SDS-PAGE and stained with comassie blue.Fig. 1. Effect of KH7 and isoproterenol on the overall cellular and mitoplast level of cAMP in
human ﬁbroblast cultures. cAMP level in the cell homogenate andmitoplast fraction. Exper-
imental conditions:■ﬁbroblasts grown inDMEMwith10% fetal bovine serum; ﬁbroblasts
treated for 35minwith 1 μMisoproterenol;□ﬁbroblasts treated for 35minwith25 μMKH7.
The histograms represent themean values of three ormore cAMPdeterminations expressed
as percentage with respect to the control homogenate. Error bars indicate standard devia-
tions. For other experimental details see under Materials and methods.2.11. Animals
All experiments were performed in accordance with national and
institutional guidelines for animal welfare, adhering to protocols ap-
proved by the institutional committee on research animal care. A written
conﬁrmation of authorization was obtained from local authority (n.
60895-X10, Comitato Etico per la Sperimentazione Animale, Area
Sicurezza sul Lavoro, Dipartimento Amministrativo per la Sanità, Univer-
sity of Bari).3. Results
3.1. Effect of intramitochondrial cAMP on the activity of respiratory chain
complexes and cellular H2O2 level in ﬁbroblast cultures
Analysis of the cellular and mitochondrial cAMP levels in human
ﬁbroblast cell cultures shows (Fig. 1) that, under the experimental con-
ditions used, the mitochondrial contribution to the total cellular cAMP
content amounted to about 30%. β-agonist stimulation (isoproterenol
1 μM, 35 min) increased the cellular level of cAMP, without any effect
on its amount in the mitochondrial fraction. Treatment of ﬁbroblast
cultures with KH7 (25 μM, 35 min), which reduced by approximately
30% the overall cellular cAMP content, suppressed almost completely
the mitochondrial cAMP content.
The enzymatic activities of the respiratory chain complexes were
then analyzed (Fig. 2). KH7 treatment of ﬁbroblast cultures depressed
the activities of complex I and complex IV, both activities being rescued
by 8-Br-cAMP, but not by isoproterenol. No effect was observed on the
activities of complex II/III. KH7 treatment of the ﬁbroblast cultures, in
the exponential growth-phase, resulted also in a large increase of the cel-
lularH2O2 level, whichwas, in this case, prevented by 100 μM8-Br-cAMP,
but not by isoproterenol (Fig. 2D).
Treatment of the ﬁbroblast culture with the carbonic anhydrase in-
hibitor (CAI) [33], caused, like KH7, inhibition of complex I and complex
IV activities and promoted ROS production. These effects of CAI were
rescued, as observed with KH7, by 8-Br-cAMP (Fig. 2, panels E, F, G).
3.2. KH7 affects the level of speciﬁc nuclear-encoded complex I subunits in
ﬁbroblast cultures
The amounts in the ﬁbroblast lysate of the NDUFA9, NDUFS4 and
NDUFV2 nuclear-encoded subunits of complex I, were decreased upon
35 min treatment of the ﬁbroblast cultures with KH7 (Fig. 3A). It has
to be noted that, according to the molecular weight-exhibited in the
SDS-PAGE run, the immunodetected spots represent the mature forms
of these subunits, produced in the cytosol, after their import in mito-
chondria and cleavage of the presequences by mitochondrial maturase
[21]. The KH7-induced decrease of the amount of these subunits was
prevented by the concomitant presence in the ﬁbroblast cultures of 8-
Br-cAMP, but not by isoproterenol. Treatment of the ﬁbroblasts with
CAI caused, like KH7, a decrease of NDUFA9, NDUFV2 and NDUFS4
subunits of complex I, which was rescued, as observed with KH7,
by 8-Br-cAMP (Supplementary Fig. 1). KH7 and CAI treatments of
the ﬁbroblast cultures, alone and in the presence of 8-Br-cAMP or
Fig. 2. Effects of KH7, CAI, isoproterenol and 8-Br-cAMP treatment on the activity respiratory chain complexes and H2O2 level in ﬁbroblast cultures. The NADH:ubiquinone oxidoreductase
(Panels A and E), cytochrome c oxidase (Panels B and F) and succinate-cytochrome c oxidoreductase (Panel C) activities were determined in the ﬁbroblast mitoplast fraction, isolated as
described under Materials and methods. Panels D and G, H2O2 level in ﬁbroblasts, detected ﬂuorimetrically by the H2DCFDA probe and expressed as relative ﬂuorescence intensity (IF).
Experimental conditions: (CTRL) ﬁbroblasts grown in DMEM with 10% fetal bovine serum; (KH7) ﬁbroblasts treated for 35 min with 25 μM KH7; (KH7 + ISO) ﬁbroblasts treated for
35 min with KH7 plus 1 μM isoproterenol; (KH7 + 8br) ﬁbroblasts treated for 35 min with KH7 plus 100 μM 8-Br-cAMP; (CAI) ﬁbroblasts treated for 35 min with 1 μM CAI; (CAI + 8br)
ﬁbroblasts treated for 35minwith CAI plus 8-Br-cAMP. The histograms represent themean values of three ormore determinations. Errors bars indicate standard deviations. For experimental
details see under Materials and methods.
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in the amount of the membrane embedded nuclear-encoded NDUFB6
and NDUFB11-subunits of complex I (Fig. 3A and Supplementary Fig. 1)
neither in the amount of core II subunit of complex III, subunit IV of com-
plex IV and the β subunit of complex V (FoF1 ATP synthase) (Fig. 3A). The
addition of valinomycin or CCCP to the ﬁbroblast cultures had, on the
other hand, no effect on the amounts of the NDUFS4 and NDUFA9 sub-
units of complex I in the ﬁbroblast lysate (Fig. 3, inset). KH7 treatment
of the ﬁbroblast cultures resulted in a signiﬁcant decrease of the amount
of the NDUFS4 subunit in the totalmitoplast fraction (Fig. 3B), but had no
effect on the amount of this subunit, as well as of the NDUFA9 and
NDUFB6 subunits, in the inner-membrane mitochondrial fraction of the
mitoplasts (Fig. 3C). Two-dimensional, blue-native/SDS-PAGE and
western blotting of respiratory chain complexes show that the KH7
and 8-Br-cAMP treatment of the ﬁbroblast cultures did not have, in the
short term incubation used (35 min), any effect on the amount of the nu-
clear encoded subunits in the assembled complex I, as well as in complex
III, IV and V (Fig. 3D).
3.3. KH7 affects the accumulation of complex I subunits in isolated rat liver
mitochondria
The effect of sAC inhibition by KH7 on the mitochondrial import/
accumulation of newly synthesized complex I subunits was examined in
a hybrid experimental model in which the import into isolated rat liver
mitochondria (RLM) of [35S]Met/Cys radiolabeled subunits of the com-
plex, produced “in vitro” by expression in the rabbit reticulocyte lysate
(RRL) of their full-length human cDNA was followed. The autoradiogra-
phy patterns presented in Fig. 4A show that the [35S] labeled NDUFS4
protein was imported into RLM, where it underwent cleavage of the
presequence, generating the mature form (with lower molecular
weight). The precursor, bound to the surface of mitochondria, was
completely digested by trypsin treatment (see also [21]). The amount of
the mitochondria imported NDUFS4, which was increased by addedpuriﬁed catalytic subunit of PKA (see also [21]), was depressed by KH7.
TheKH7-dependent decrease of the importedNDUFS4proteinwas, how-
ever, not prevented by the addition of PKA. RLM, used in the import
experiments, were also processed by BNE to separate the assembled re-
spiratory chain complexes. The autoradiography shows that the imported
[35S] labeled NDUFS4 was incorporated in the RLM complex I. The incor-
poration was enhanced by PKA (Fig. 4B), but depressed by KH7. This
effect of KH7 was prevented by 8-Br-cAMP, but not by added PKA. The
import into RLM of two other “in vitro” expressed [35S] labeled subunits
of complex I, namely NDUFV2 and NDUFB11, was also followed (Fig. 4C
and D). KH7 depressed, as observed for NDUFS4, themitochondrial accu-
mulation of the NDUFV2 subunit and its incorporation in the RLM com-
plex I. The depressing effect exerted by KH7 on NDUFS4 and NDUFV2
was rescued by 8-Br-cAMP. Themitochondrial import of the [35S] labeled
NDUFB11 subunit was, on the other hand, unaffected by KH7 and 8-Br-
cAMP. It can also be noted that, in the short incubation time used
(35 min), the newly imported [35S] labeled NDUFB11 did not assemble
in the RLM complex I (Fig. 4D). In these experiments the immunoblot
spot of the NDUFB6 subunit was used as amarker of the location of com-
plex I in the native gel, and the immunoblot density of COX-IV subunit as
a marker for protein loading in the gel (see Fig. 4B and D).
3.4. Effect inﬁbroblast cultures of protease inhibitors on the level of subunits
and activity of complex I
The level of the mature, nuclear-encoded subunits of complex I is
likely to be determined by the balance between their expression, mito-
chondrial import/maturation, and proteolytic digestion by mitochon-
drial proteases, as well as by the proteasome, for those copies of the
subunits which undergo retrograde back diffusion in the cytosol (see
[21,35]). Treatment of the ﬁbroblast cultures with MG132, an inhibitor
of proteasome, as well as of mitochondrial Lon protease [35,36],
prevented the KH7-induced decrease of the level of NDUFA9, NDUFS4
andNDUFV2 in theﬁbroblast lysate (Fig. 5A). The level of themembrane
Fig. 3. Effect of KH7 treatment on the levels of mitochondrial respiratory chain subunits in ﬁbroblast cultures. Fibroblasts were cultivated in standard culture conditions (CTRL), treated
35minwith KH7 (KH7), with KH7 plus isoproterenol (KH7+ ISO), or KH7 plus 8-Br-cAMP (KH7+ 8br). Proteins of cellular lysate (Panel A) andmitoplast fraction (Panel B)were loaded
on 12% SDS–PAGE, transferred to nitrocellulosemembranes and immunoblottedwith the antibodies against the subunits speciﬁed in theﬁgure. Protein loadingwas assessed by reprobing
the blots with the β-actin antibody. Panel C, the pellet of the inner mitochondrial membrane, obtained by sonication of the mitoplast fraction was resuspended in 30 μl of PBS, proteins
separated by SDS/PAGE and subjected to immuno-detection with the antibodies described in the ﬁgure. Panel D, mitoplast proteins were processed by 2D, BNE/SDS-PAGE, followed by
transfer to nitrocellulose membranes for immuno-detection with antibodies against complex I (NDUFA9 and NDUFB6), complex III (core II), complex IV (COX IV), and complex V (β-ATPase)
subunits. The histograms represent the percentage changeswith respect to theADU (arbitrary densitometric units) of control untreatedﬁbroblasts. The values aremeans± standard deviation
of three separate experiments. * pb 0.05, KH7 vs CTRL; # pb 0.05KH7+8br vsKH7; Student's t test. For other details see legend to Fig. 2 andunderMaterials andmethods. The inset shows the
effects of valinomycin and CCCP treatment on the levels of complex I subunits in ﬁbroblast cultures. Experimental conditions: (CTRL) ﬁbroblasts grown in DMEMwith 10% fetal bovine serum;
(Val)ﬁbroblasts treated for 35minwith5 μMvalinomycin; (CCCP)ﬁbroblasts treated for 35minwith 2 μMCCCP. Proteins fromﬁbroblast cell lysatewere loadedon12% SDS–PAGE, transferred
to nitrocellulosemembranes and immunoblottedwith the antibodies against the subunits speciﬁed in theﬁgure. Protein loadingwas assessed by reprobing the blotswith theβ-actin antibody.
The histograms represent the percentage changes with respect to the ADU of control untreated ﬁbroblasts. The values are means ± standard deviation of three separate experiments.
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Epoxomicin, which is a speciﬁc proteasome inhibitor [37], exerted a
smaller sparing effect on the KH7-induced decrease of the level of the
NDUFA9, NDUFS4 and NDUFV2 subunits (Fig. 5A). Direct immunoassay
showed that MG132 had no effect on the overall amount of the nuclear-
encoded subunits in the assembled complex I separated by 2D (blue
native/SDS-PAGE) from the KH7-treated ﬁbroblasts (Fig. 5, inset).
The sparing effect exerted by MG132 on the KH7-induced decrease
of the subunits prevented the KH7-induced depression of the enzymatic
activity of complex I (Fig. 5B). The smaller sparing effect exerted by
epoxomicin on the level of the subunits had, on the other hand, no effect
on the KH7-induced inhibition of complex I activity. It can also be noted
that MG132 or epoxomicin treatment of the ﬁbroblast cultures had no
effect on the KH7-induced depression of the enzymatic activity of com-
plex IV (Fig. 5C).
3.5. Effect ofMG132 and epoxomicin on the import/accumulation in RLM of
[35S] labeled complex I subunits
The sparing effect of protease inhibitors on the mitochondrial accu-
mulation ofmatrix-exposed subunits of the complexwas also veriﬁed inthe RLM importmodel. The results presented in Fig. 6 show thatMG132,
but not epoxomicin, prevented the KH7-induced decrease of the accu-
mulation in RLM of the [35S] labeled NDUFS4 and NDUFV2 subunits
(Fig. 6A). MG132 but not epoxomicin prevented the KH7-induced de-
crease of the amount of the [35S] labeled NDUFS4 subunit incorporated
in the RLM complex I (Fig. 6B).
3.6. Modulation of RLM protease activity by effectors of the cAMP system
The mitochondrial protease activity of RLM was measured by
following the digestion of casein by Triton X-100 permeabilized organ-
elles. After incubation of RLM with KH7, KH7 plus MG132 or KH7 plus
epoxomicin, a protein kinase inhibitors (PKI) and okadaic acid, phospha-
tase inhibitor, were added to the incubation mixture, before adding
casein, to prevent any possible change in the intrinsic phosphorylation
state of casein used in the measurements. The results (Fig. 7) show that
RLM treatment with KH7 promoted the digestion of casein, which was
completely blocked by MG132, but unaffected by epoxomicin. The KH7
induced digestion of casein by RLMwas largely prevented by the addition
to the incubation mixture of 8-Br-cAMP (Fig. 7C). On the other hand, the
addition of the PKA inhibitor H89, promoted casein degradation (Fig. 7C).
Fig. 4. Effect of KH7 on the accumulation of “in vitro” produced complex I subunits in isolated rat-livermitochondria. [35S]Met-labeledNDUFS4, NDUFV2 and NDUFB11 proteinswere pro-
duced by “in vitro” RRL transcription/translation of full length human cDNAs of the subunits. 5-μl aliquots of the RRL translation mixture were added to the RLM import mixture. Panel
A, mitochondrial import of [35S] labeled NDUFS4. Experimental conditions: (CTRL) no addition; (PKA) import incubation in the presence of cPKA (1 unit per 10 μg mitochondrial
proteins) plus 7.5 mM sodium ﬂuoride; (KH7) import incubation in the presence of 50 μM KH7; (PKA + KH7) import incubation in the presence of KH7 plus cPKA. After 60 min
incubation at 30 °C, mitochondria were spun down from the importmixture, before or after trypsin treatment (1 μg per 50 μgmitochondrial proteins, 35min on ice) as speciﬁed in the ﬁgure.
The solubilized pellets, containing 50 μg of mitochondrial proteins, were analyzed by SDS–PAGE and autoradiography. Panel B, Mitochondrial proteins of trypsinized samples in Panel A were
spun down from the import mixture and analyzed by BNE and autoradiography. The location of assembled complex I was assessed by immunoblotting with an antibody against the NDUFB6
subunit of complex I. Protein loading was assessed by probing the membrane with the COX IV antibody. Panel C, mitochondrial import experiments of [35S] labeled NDUFS4, NDUFV2 and
NDUFB11. Experimental conditions: (CTRL) no addition; (KH7) import incubation in the presence of KH7; (KH7 + 8br) import incubation in the presence of KH7 plus 100 μM 8-Br-cAMP.
Panel D,Mitochondrial proteins of trypsinized samples in Panel Cwere spun down from the importmixture and analyzed by blue native electrophoresis and autoradiography. The histograms
show themeanADU (as percentage of control) of radioactive bands corresponding to the trypsin-resistantmature formof radiolabeled proteins (panels A and C) and of the radiolabeled bands
incorporated in complex I (panels B andD). The values aremeans± standard deviation of three separate experiments. * p b 0.05, ** p b 0.01: PKA vs CTRL, KH7 vs CTRL; # p b 0.05, KH7+8br
vs KH7; Student's t test. For other details see under Materials and methods.
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In mammalian cells the nuclear-encoded subunits of complex I are
continuously imported into mitochondria, where they are integrated,
in sequential steps, with the mitochondrial-encoded subunits to form
the mature functional complex, or separately exchanged with their
pre-existing copies in the complex [5,7,8]. The results from previous
[8,9,21] and present work show that both cytosolic and mitochondrial
pools of cAMP regulate the turnover of speciﬁc nuclear encoded
subunits of complex I. Phosphorylation of the NDUFS4 subunit by
extramitochondrial PKA promotes the mitochondrial import of the
precursor of the protein [21]. The results of the present work show
that the intramitochondrial cAMP, produced by sAC,modulates the con-
centration of this and other speciﬁc nuclear-encoded subunits of the
catalytic moiety of complex I and its NADH-ubiquinone oxidoreductase
activity.
Treatment of ﬁbroblast cultures with KH7, which inhibits intra-
mitochondrial production of cAMP (Fig. 1), causes a marked (35–50%)
decrease of the overall amount of the mature forms of the nuclear-encoded NDUFS4, NDUFV2 and NDUFA9 subunits of complex I, but left
unaffected their total amount in the assembled complex in the inner
mitochondrial membrane. Of these subunits, which are the last to be
assembled in the complex, NDUFS4 and NDUFV2 belong to the NADH
dehydrogenase (N) module, NDUFA9 to the electron output (Q) module
[5]. No effect of KH7 was, on the other hand, exerted on the level of the
nuclear-encoded NDUFB6 and NDUFB11 subunits, which belong to the
membrane embeddedmoiety of complex I [5]. TheKH7-induceddecrease
of the nuclear-encoded subunits of complex I, which are essential for the
NADH-ubiquinone oxidoreductase of the enzyme, was associated with
depression of the activity of complex I. This was accompanied as already
observed in other cases [9] by enhanced level of cellular H2O2. Both KH7
effects were counteracted by the membrane permeant 8-Br-cAMP, but
not by isoproterenol-induced production of cAMP in the cytosol. Effects
similar to those of KH7, were reproduced by treatment of the ﬁbroblast
cultures with acetazolamide, a carbonic anhydrase inhibitor (CAI),
which also causes a decrease in the mitochondrial level of cAMP [33].
The observed marked decrease of the overall amount of the NDUFS4,
NDUFV2 and NDUFA9 subunits, caused by KH7 and CAI in the ﬁbroblast
Fig. 5. Effect ofMG132 and epoxomicin onKH7-dependent induceddecrease of subunit levels and activity of complex I inﬁbroblast cultures. Panel A, Immuno-detection of subunit levels in the
ﬁbroblast lysate. Panel B, NADH:ubiquinone oxidoreductase activity determined in the ﬁbroblast mitoplast fraction. Panel C, cytochrome c oxidase activity determined in the ﬁbroblast
mitoplast fraction. Fibroblastswere cultivated in standard culture conditions (CTRL); treated 35minwith 25 μMKH7 (KH7); KH7 plus 10 μMMG132 (KH7+MG); KH7 plus 5 μMepoxomicin
(KH7 + EPO). The histograms represent the percentage changes with respect to the ADU of control untreated ﬁbroblats. The values are means ± standard deviation of three independent
experiments. * p b 0.05, ** p b 0.01: KH7 vs CTRL; # p b 0.05, ## p b 0.01: KH7+ MG132 vs KH7, KH7+EPO vs KH7. Student's t test. For other details see legend to Fig. 3 and underMaterials
andmethods. The histograms in the inset represent the densitometric semiquantitative analysis of the assembled subunits of the respiratory chain complexes. Fibroblast cultureswere treated
with KH7 and KH7 plus MG132. After 35 min incubation, the mitoplasts were isolated, proteins separated by 2D, BNE/SDS-PAGE, and transferred to nitrocellulose membranes for immuno-
detection with the speciﬁed antibodies.
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accounts for about one half of their total cellular amounts.
The depressing effect exerted by KH7 on the mitochondrial amount
of mature form of the subunits of complex I was veriﬁed in the experi-
mental model in which the import/accumulation in RLM of “in vitro”
expressed [35S] labeled human NDUFS4 and NDUFV2 subunits was
followed. Previouswork from our laboratory has shown that phosphor-
ylation of the C-terminal RVS conserved site of the nuclear-encoded
NDUFS4 subunit of complex I [20] by extramitochondrial PKA promotes
the membrane potential driven mitochondrial import of the precursor
form of the protein [21]. The imported precursor, processed by mito-
chondrial maturase with cleavage of the positively charged leader
sequence, generates the mature form which is then incorporated in
the complex (see Fig. 4). It can be noted the positive outcome of this hy-
brid import system conﬁrms the functional inter-species equivalence of
these subunits, whose human and rat aminoacid sequences present
more than 90% identity ([20], sequences obtained and aligned with
UniProt website). The accumulation of [35S] labeled human NDUFS4
and NDUFV2 proteins in RLM and their incorporation in the RLM com-
plex I were depressed by KH7. This inhibitory action of KH7 too was
completely prevented by 8-Br-cAMP. The mitochondrial accumulationof the membrane integral [35S] labeled NDUFB11 subunit was, on the
other hand, unaffected by KH7 and 8-Br-cAMP.
Insight into the mechanism of this role of intramitochondrial cAMP is
provided by the experiments inwhich the effect of protease inhibitors on
the KH7-induced decrease of the amount of these subunits was tested.
Treatment of ﬁbroblast cultures with MG132, an inhibitor of the protea-
some as well as of Lon, completely prevented the KH7-induced decrease
of the non-incorporated amounts of the NDUFA9, NDUFS4 and NDUFV2
subunits. Epoxomicin, which inhibits only the proteasome, exerted a
smaller protective effect against the KH7-induced decrease of these sub-
units. MG132, but not epoxomicin, prevented the KH7-induced depres-
sion of complex I activity. It can also be noted that MG132 had no effect
on the KH7-induced inhibition of cytochrome c oxidase.
The sparing effect of MG132 was also observed in the RLM import
model, in which it prevented the depressing action of KH7 on the accu-
mulation in mitochondria of [35S] labeled NDUFS4 and NDUFV2 sub-
units and their incorporation in the RLM complex I. In this system
epoxomicin did not prevent the KH7 depression of subunit accumula-
tion in RLM and incorporation in the RLM complex I. These ﬁndings
show that the intramitochondrial critical amount of speciﬁc nuclear-
encoded subunits, of the catalytic moiety of the complex, is controlled
Fig. 6.KH7-induceddecrease of accumulationof complex I subunits in rat-livermitochondria
is preventedbyMG132butnot by epoxomicin. Panel A,mitochondrial import experiments of
[35S] labeled NDUFS4 and NDUFV2. (CTRL), no addition; (KH7), import incubation in the
presence of 50 μM KH7; (KH7 + MG), import incubation in the presence of KH7 plus
10 μM MG132; (KH7 + EPO) import incubation in the presence of KH7 plus 5 μM
epoxomicin. After 60 min incubation at 30 °C, mitochondria were spun down from the
import mixture before or after trypsin treatment. The solubilized pellets, containing 50 μg
of mitochondrial proteins, were analyzed by SDS–PAGE and autoradiography. Panel B, Mito-
chondrial proteins of trypsinized samples in Panel A were spun down from the import mix-
ture and analyzed by BNE and autoradiography. Protein loadingwas assessed by probing the
membranewith the COX IV antibody. The histograms show themean ADU (as percentage of
control) of radioactive bands corresponding to the trypsin-resistant mature form of
radiolabeled proteins (panel A) and of the radio-labeled bands incorporated in complex I
(panel B). The values are means ± standard deviation of three separate experiments.
* p b 0.05, ** p b 0.01: KH7 vs CTRL; # p b 0.05: KH7+ MG132 vs KH7; Student's t test. For
other details see legend to Fig. 4 and under Materials and methods.
Fig. 7. Effect of KH7, 8-Br-cAMP and H89 on proteolysis of casein in rat livermitochondria.
Panel A, casein digestion was followed in triton X-100 solubilized RLM incubated in the
presence of 50 μM KH7 plus 10 μMMG132 (KH7 +MG, ﬁlled circles of the plot) or in the
presence of KH7 plus 5 μM epoxomicin (KH7 + EPO, open squares of the plot) at 30 °C,
for the time intervals indicated in the ﬁgure. After incubation, proteins were separated by
SDS-PAGE and stained with comassie blue. The lane (RLM) represents the SDS-PAGE of
RLM proteins incubated in the absence of added casein. Lane (C) represents the SDS-PAGE
of the puriﬁed casein sample. The ADU of stained puriﬁed casein (in lane C) represents the
100% of the input counts. Panel B, the plots represent the ADU of the stained casein,
expressed as percentage of input counts. Panel C, casein digestionwas followed in RLM incu-
bated for 60min at 30 °C in the absence (CTRL), in the presence of 50 μMKH7 (KH7), in the
presence of KH7 plus 100 μM 8-Br-cAMP (KH7 + 8br), in the presence of 100 nM H89
(H89). The histograms represent the ADU of the stained casein, expressed as percentage of
input counts. The values are means of three determinations. * p b 0.05: KH7 vs CTRL and
H89 vs CTRL; # p b 0.05: KH7 + 8br vs KH7. Student's t test. For other details see under
Materials and methods.
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proteolytic degradation [38,39].
Mitochondrial proteases include two AAA proteases, the Lon prote-
ase, the metallopeptidase OMA1 and the ClpXP protease [39]. MG132,
which is reported to inhibit in addition to the proteasome also the Lon
protease [35,36], completely prevented the KH7 induced digestion of
puriﬁed casein by RLMextract, as, indeed, observed for the KH7 induced
digestion of nuclear encodedNDUFA9, NDUFS4 andNDUFV2 subunits of
complex I in ﬁbroblast cultures (Fig. 5) as well as the digestion of the
radiolabeled NDUFS4 and NDUFV2 subunits incorporated in vitro in
RLM (Fig. 6). These observations favor the Lon protease as responsible
for the KH7 promoted proteolysis of the nuclear-encoded subunits of
complex I. This doesn't, however, exclude the possibility that the other
mitochondrial protease(s) are also involved.The KH7-promoted digestion of speciﬁc nuclear-encoded subunits
of complex I was completely prevented by the concomitant addition
of 8-Br-cAMP. Also the KH7-induced digestion of casein by RLM extract
was prevented by 8-Br-cAMP, and promoted by the PKA inhibitor H89.
This shows that the KH7-induced proteolysis involves the cAMP system.
Collapse of mitochondrial membrane potential by valinomycin, or the
uncoupler CCCP, in ﬁbroblast cultures did not induce, on the other
hand, degradation of the NDUFA9 and NDUFS4 subunits of complex I
(inset in Fig. 3). It can also be noted that KH7 did not promote degrada-
tion of the NDUFB11 subunit in ﬁbroblast cultures (Fig. 3), neither its
import in RLM in vitro, a process which, like the import of NDUFS4, is
Δψ dependent (see also [21]). This seems to exclude the possibility
that, at least under the prevailing experimental conditions used, the
191D. De Rasmo et al. / Biochimica et Biophysica Acta 1853 (2015) 183–191KH7 effects on complex I subunits and activity, in addition to the
depression of the cAMP system, involve also changes in membrane po-
tential. The increase in ROS level induced by KH7 treatment of ﬁbroblast
cultures, which was prevented by 8-Br-cAMP, could also be involved in
the KH7-induced degradation of the NDUFS4, NDUFV2 and NDUFA9
subunits (see ref. [40]). The minor sparing effect on the KH7-induced
decrease of complex I subunits, produced by epoxomicin inhibition of
the proteasome in ﬁbroblast cultures, is likely due to inhibition of
degradation in the cytosol of the mature forms of complex I subunits
released from mitochondria by retrograde back diffusion [cf. 21]. Obvi-
ously the sparing effect of this fraction of subunits has no effect on the
catalytic activity of complex I in mitochondria.
In conclusion regulation by cytosolic and mitochondrial cAMP of
the import and proteolytic processing respectively controls the
intramitochondrial level of free nuclear encoded NDUFS4, NDUFV2 and
NDUFA9 subunits of complex I. These subunits, belonging to the catalytic
moiety of the complex, which protrudes in thematrix space, are exposed
to oxidative damage by ROS produced in this space [6–8].Maintenance of
a substantial intramitochondrial free pool of these subunits contributes to
preserve the functional capacity of complex I by replacing ROS damaged
subunits in the assembled complex with newly produced copies [8].
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2014.10.016.
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